In Brief: Ivax Paxene
Executive Summary
Ivax Paxene: FDA Oncologic Drugs Advisory Committee meeting Sept. 19 at 8 a.m. will review Ivax' paclitaxel for AIDS-related KS in the morning, followed by discussion of Bristol's Droxia (hydroxyurea) sNDA (16-295) for treatment of sickle cell anemia in adults, prevention of painful crisis and reduction in the need for blood transfusions...